Cabinet de médecine nucléaire du Docteur Pascale Parizel
0848.633.501 · rovalta.com · 28/09/2026
Cabinet de médecine nucléaire du Docteur Pascale Parizel
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCabinet de médecine nucléaire du Docteur Pascale Parizel is a Private company with limited liability incorporated in 2012. Its registered office is in Namur.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0848.633.501
- Incorporation
- 12/09/2012
- Legal form
- Private company with limited liability
- Registered office
- Allée des Fleurs(BZ) 25 box b
5000 Namur · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 26,5 k € | -2.5% | 27,2 k € | +2.3% | 26,6 k € | +18.4% | 22,5 k € | -52.1% | 46,9 k € |
| EBITDA | 26,1 k € | -2.6% | 26,8 k € | +2.3% | 26,2 k € | +18.7% | 22 k € | -52.5% | 46,4 k € |
| Operating result | 12,5 k € | +6.0% | 11,8 k € | +5.4% | 11,2 k € | +675% | -1,9 k € | -110% | 19,1 k € |
| Net result | 10,9 k € | +32.7% | 8,2 k € | -7.2% | 8,9 k € | +500% | -2,2 k € | -117% | 13,4 k € |
| Balance sheet | |||||||||
| Equity | 118,7 k € | +10.1% | 107,8 k € | +8.3% | 99,5 k € | +9.8% | 90,6 k € | -2.4% | 92,9 k € |
| Total assets | 131,6 k € | +9.1% | 120,6 k € | +8.3% | 111,4 k € | +7.0% | 104,1 k € | -9.8% | 115,4 k € |
| Cash | 103,1 k € | +56.0% | 66,1 k € | +71.3% | 38,6 k € | +102% | 19,1 k € | +580% | 2,8 k € |
| Debts | 12,9 k € | +0.2% | 12,8 k € | +8.3% | 11,8 k € | -12.1% | 13,5 k € | -40.1% | 22,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Pascale PARIZEL | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/07/2026 | 20/08/2025 | 26/08/2024 | 19/07/2023 | 11/07/2022 | 28/07/2021 |
| General meeting | 06/05/2026 | 07/05/2025 | 01/05/2024 | 03/05/2023 | 04/05/2022 | 05/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 06/05/2026 | 20/07/2026 | French | |
| Micro model | 31/12/2024 | 07/05/2025 | 20/08/2025 | French | |
| Micro model | 31/12/2023 | 01/05/2024 | 26/08/2024 | French | |
| Micro model | 31/12/2022 | 03/05/2023 | 19/07/2023 | French | |
| Micro model | 31/12/2021 | 04/05/2022 | 11/07/2022 | French | |
| Micro model | 31/12/2020 | 05/05/2021 | 28/07/2021 | French | |
| Micro model | 31/12/2019 | 06/05/2020 | 22/06/2020 | French | |
| Micro model | 31/12/2018 | 01/05/2019 | 22/08/2019 | French | |
| Micro model | 31/12/2017 | 02/05/2018 | 24/08/2018 | French | |
| Micro model | 31/12/2016 | 03/05/2017 | 30/08/2017 | French | |
| Abridged model | 31/12/2015 | 04/05/2016 | 22/09/2016 | French | |
| Abridged model | 31/12/2014 | 06/05/2015 | 08/07/2015 | French | |
| Abridged model | 31/12/2013 | 07/05/2014 | 04/08/2014 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Pascale PARIZEL | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Allée des Fleurs(BZ) 25 bte b, 5000 NamurCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00318962 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Cabinet de médecine nucléaire du Docteur Pascale ParizelCurrent | CBE | |
| CAB. MED. NUC DU DOCTEUR PASCALE PARIZEL | accounts 2021 → 2025 | Accounts 2025 · 2026-00318962 |
Events
- 2025Annual accounts 202510,9 k €↑
- 2024Annual accounts 20248,2 k €↓
- 2023Annual accounts 20238,9 k €↑
- 2022Annual accounts 2022-2,2 k €↓
- 2021Annual accounts 202113,4 k €↓
- 2020Annual accounts 202017,2 k €↑
- 2019Annual accounts 20198,8 k €↓
- 2018Annual accounts 201814,9 k €↑
- 2017Annual accounts 20172 k €↓
- 2016Annual accounts 20165,5 k €↑
- 2015Annual accounts 20154 k €↓
- 2014Annual accounts 20147,4 k €↑
- 2013Annual accounts 20137,1 k €
- 12/09/2012IncorporationPrivate company with limited liability